Skip to search.
 TSX Up 0.21% TSX Ventures Up 1.43%

Gilead Sciences Inc. (GILD)

-NasdaqGS
79.47 Down 1.77(2.18%) 4:00PM EDT
|After Hours : 79.55 Up 0.08 (0.10%) 7:59PM EDT
Prev Close:81.24
Open:80.60
Bid:79.47 x 1000
Ask:79.59 x 200
1y Target Est:106.35
Beta:1.21468
Earnings Date:Oct 25 - Oct 31 (Est.)
Day's Range:79.37 - 80.84
52wk Range:77.92 - 120.37
Volume:19,465,672
Avg Vol (3m):9,985,940
Market Cap:105.77B
P/E (ttm):6.97
EPS (ttm):11.39
Div & Yield:1.88 (2.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 2.18%105.77B
GSKDown 0.24%109.48B
PFEUp 0.60%223.73B

Key Statistics

Forward P/E (1 yr):6.76
P/S (ttm):3.34
Ex-Dividend Date:14-Jun-16

Analysts

Annual EPS Est (Dec-16) :11.79
Quarterly EPS Est (Sep-16) :2.88
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):86.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback